Position in GH
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$82,516
+$31,713 QoQ
Shares Held
550
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#472
of 597 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026HighMark Wealth Management LLC holds $9,276,436 across 7 Diagnostics & Research names. GH ranks #4 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NEO |
Neogenomics Inc
|
612,534 | $8,936,871 | |
| 2 | DHR |
Danaher Corp /De/
|
560 | $106,668 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
199 | $104,761 | |
| 4 | GH |
Guardant Health, Inc.
This page
|
550 | $82,516 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
|
75 | $37,602 | |
| 6 | A |
Agilent Technologies, Inc.
|
58 | $7,704 | |
| 7 | QUCY |
Quantum Cyber N.V.
|
200 | $314 |
All Filings in GH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $82,516 | 550 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $50,803 | 550 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $56,177 | 550 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $34,364 | 550 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $28,622 | 550 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $23,430 | 550 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $16,802 | 550 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $12,617 | 550 | Shares | Sole | 2024-10-17 | |
| No filing history on record for this holder in this stock. | ||||||